In patients with cirrhosis-related cardiac disease, BNP levels measured at four key time points (T1–T4) have demonstrated 100% sensitivity and 91.9% specificity for detecting cardiac involvement44,77,78. This evidence concerns the gene NPPB and heart disorder.